Sales growth remains similar to the preceding year with solid growth of photovoltaic, cosmetic business line and Master-Batch business line.Loss increased with rising expenses due to impairment losses on intangible assets, with sales cost exceeding sales.Market competitiveness is expanded as it obtained international patent for atopic disease medicine and its subsidiary For Humantech started selling stem cell materials. Sales will grow as it was designated as ¡®Good Partner¡¯ by Honam Petrochemical and Master-Batch business line advanced into the Turkish market.Profitability will improve with declining fixed cost and prices of raw materials.Working capital will be smoothly secured through capital increase by public offering.
Headquarters
2144, HWADONG-RI, HWAYANG-MYEON, YEOSU-SI, JEOLLANAM-DO
Yeosu; Jeollanam;
Postal Code: 555290
Contact Details: Purchase the Poly Plus Co., Ltd. report to view the information.
Website: http://www.polyplus.biz
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service